跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Coxibral - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Coxibral
Approved
STANDARD
Coxibral
Ratnatris Pharmaceuticals Pvt. Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9b04938c24c87c6e
Company
Ratnatris Pharmaceuticals Pvt. Ltd
Type
Standard
Approval Details
Approval Id
9b04938c24c87c6e
Drug Approval Philippines Name
Coxibral
Product Name
Coxibral
Registration Number
DRP-12528-01
Brand Name
Coxibral
Generic Name
Celecoxib
Dosage Form
Capsule
Dosage Strength
200 mg
Manufacturer
Ratnatris Pharmaceuticals Pvt. Ltd
Importer
Medinova Pharmaceutical Inc.
Distributor
Reta Drug
Issuance Date
26 November 2023
Expiry Date
26 August 2027
Pharmacologic Category
Non-Steroidal Anti-Inflammatory Drug (NSAID)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9b04938c24c87c6e
Type
Standard
Back to Philippines FDA Approvals